Pharming Group N.V. (ENXTAM:PHARM) is looking for acquisitions. Jeroen Wakkerman, Chief Financial Officer said, "We continue to focus on potential acquisitions and in-licensing of clinical stage opportunities in rare diseases in therapeutic areas like immunology, hematology, respiratory and gastroenterology, and that is to further leverage our commercial infrastructure globally".